Intetumumab
- Generic Name
- Intetumumab
- Brand Names
- -
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- 725735-28-4
- Unique Ingredient Identifier
- GQE1BJE2NI
- Background
Intetumumab has been used in trials studying the treatment of Melanoma.
- Associated Conditions
- -
- Associated Therapies
- -
A Safety and Efficacy Study of Intetumumab, Alone and in Combination With Dacarbazine, in Participants With Stage 4 Melanoma
- First Posted Date
- 2005-10-30
- Last Posted Date
- 2013-08-19
- Lead Sponsor
- Centocor, Inc.
- Target Recruit Count
- 144
- Registration Number
- NCT00246012
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath